Literature DB >> 18486177

Arsenic alters vascular smooth muscle cell focal adhesion complexes leading to activation of FAK-src mediated pathways.

Michele D Pysher1, Qin M Chen, Richard R Vaillancourt.   

Abstract

Chronic exposure to arsenic has been linked to tumorigenesis, cardiovascular disease, hypertension, atherosclerosis, and peripheral vascular disease; however, the molecular mechanisms underlying its pathological effects remain elusive. In this study, we investigated arsenic-induced alteration of focal adhesion protein complexes in normal, primary vascular smooth muscle cells. We demonstrate that exposure to environmentally relevant concentrations of arsenic (50 ppb As(3+)) can alter focal adhesion protein co-association leading to activation of downstream pathways. Co-associated proteins were identified and quantitated via co-immunoprecipitation, SDS-PAGE, and Western blot analysis followed by scanning densitometry. Activation of MAPK pathways in total cell lysates was evaluated using phosphor-specific antibodies. In our model, arsenic treatment caused a sustained increase in FAK-src association and activation, and induced the formation of unique signaling complexes (beginning after 3-hour As(3+) exposure and continuing throughout the 12-hour time course studied). The effects of these alterations were manifested as chronic stimulation of downstream PAK, ERK and JNK pathways. Past studies have demonstrated that these pathways are involved in cellular survival, growth, proliferation, and migration in VSMCs.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18486177      PMCID: PMC3900024          DOI: 10.1016/j.taap.2008.04.002

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  54 in total

Review 1.  Src family tyrosine kinases and growth factor signaling.

Authors:  C L Abram; S A Courtneidge
Journal:  Exp Cell Res       Date:  2000-01-10       Impact factor: 3.905

2.  Regulation of Akt/PKB activation by tyrosine phosphorylation.

Authors:  R Chen; O Kim; J Yang; K Sato; K M Eisenmann; J McCarthy; H Chen; Y Qiu
Journal:  J Biol Chem       Date:  2001-07-09       Impact factor: 5.157

Review 3.  Vascular smooth muscle growth: autocrine growth mechanisms.

Authors:  B C Berk
Journal:  Physiol Rev       Date:  2001-07       Impact factor: 37.312

4.  p21-activated kinase (PAK1) is phosphorylated and activated by 3-phosphoinositide-dependent kinase-1 (PDK1).

Authors:  C C King; E M Gardiner; F T Zenke; B P Bohl; A C Newton; B A Hemmings; G M Bokoch
Journal:  J Biol Chem       Date:  2000-12-29       Impact factor: 5.157

5.  Src is an important mediator of extracellular signal-regulated kinase 1/2-dependent growth signaling by angiotensin II in smooth muscle cells from resistance arteries of hypertensive patients.

Authors:  R M Touyz; G He; X H Wu; J B Park; M E Mabrouk; E L Schiffrin
Journal:  Hypertension       Date:  2001-07       Impact factor: 10.190

Review 6.  Recent advances in arsenic carcinogenesis: modes of action, animal model systems, and methylated arsenic metabolites.

Authors:  K T Kitchin
Journal:  Toxicol Appl Pharmacol       Date:  2001-05-01       Impact factor: 4.219

Review 7.  Focal adhesion kinase: a regulator of focal adhesion dynamics and cell movement.

Authors:  J T Parsons; K H Martin; J K Slack; J M Taylor; S A Weed
Journal:  Oncogene       Date:  2000-11-20       Impact factor: 9.867

Review 8.  Selected glimpses into the activation and function of Src kinase.

Authors:  J D Bjorge; A Jakymiw; D J Fujita
Journal:  Oncogene       Date:  2000-11-20       Impact factor: 9.867

Review 9.  Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells.

Authors:  R M Touyz; E L Schiffrin
Journal:  Pharmacol Rev       Date:  2000-12       Impact factor: 25.468

10.  Increased hexokinase II expression in the renal glomerulus of mice in response to arsenic.

Authors:  Michele D Pysher; James J Sollome; Suzanne Regan; Trevor R Cardinal; James B Hoying; Heddwen L Brooks; Richard R Vaillancourt
Journal:  Toxicol Appl Pharmacol       Date:  2007-07-04       Impact factor: 4.219

View more
  3 in total

Review 1.  Melatonin: a pleiotropic hormone as a novel potent therapeutic candidate in arsenic toxicity.

Authors:  Naseh Abdollahzade; Maryam Majidinia; Shirin Babri
Journal:  Mol Biol Rep       Date:  2021-08-28       Impact factor: 2.316

2.  Induction of heme oxygenase 1 by arsenite inhibits cytokine-induced monocyte adhesion to human endothelial cells.

Authors:  Xi Sun; Jingbo Pi; Wenlan Liu; Laurie G Hudson; Ke Jian Liu; Changjian Feng
Journal:  Toxicol Appl Pharmacol       Date:  2009-02-06       Impact factor: 4.219

3.  Mechanisms pertaining to arsenic toxicity.

Authors:  Amrit Pal Singh; Rajesh Kumar Goel; Tajpreet Kaur
Journal:  Toxicol Int       Date:  2011-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.